HIV-associated dementia (HAD) is a neurocognitive disorder that can affect individuals with HIV/AIDS. Unlike Alzheimer's disease, which primarily affects older adults and involves progressive cognitive decline, HAD is linked to the presence of HIV in the central nervous system. It often presents with symptoms such as memory loss, confusion, motor deficits, and behavioral changes. The underlying mechanisms involve HIV's ability to infect brain cells and trigger inflammation, leading to neuronal damage. Treatment focuses on managing HIV infection with antiretroviral therapy (ART), which can improve neurological symptoms and prevent progression. Unlike Alzheimer's, HAD primarily targets younger populations and underscores the importance of early HIV detection and treatment to mitigate neurological complications.
Jun Hua
Johns Hopkins University , United States
Nazneen N Dewji
Cenna Biosciences Inc, United States
Jacqueline London
Paris Diderot University, FranceSubmit your abstract Today
Title : Make a difference
Jacqueline Tuppen, Dementia UK, United Kingdom
Title : Imaging brain clearance in Alzheimer’s disease
Jun Hua, Johns Hopkins University , United States
Title : Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China
Title : Neuroimaging-based evaluation of scalp acupuncture for neural repair and reorganization in children with cerebral palsy
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China
Title : Neurophysiological change and cognitive response to levetiracetam in Alzheimer disease: Testing the missing mechanistic link
Christopher Hubler, Emergent Neural Systems Institute for Research, United States
Title : Healthcare professionals in Somaliland had low levels of knowledge and attitudes towards dementia care: A pilot survey
Mohamed Abdilahi Duale, Frantz Fanon University, Somalia